Cytosorbents Corporation

Healthcare · Medical Devices · United States

Last price 4.54 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 14.31M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform in the United States, Germany, and internationally. Its flagship product, CytoSorb, is an extracorporeal blood purification cartridge to reduce cytokine storms in common critical illnesses, bilirubin in liver failure, myoglobin in trauma and critical illnesses, and inflammatory mediators and blood thinners in cardiac surgery applications, as well as to remove antithrombotic drugs and inflammator...